Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5483523 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1828702 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5490493 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1519575 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1827086 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5485779 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5488963 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL934065 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL935232 | 0.98 | THRB (0.41) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL9438155 | 0.93 | LMNA (0.40) | THRBLMNAALKBH5SUCNR1EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12109812-B2 | Ink jet printing method and ink jet printing apparatus | SEIKO EPSON CORPORATION (JP) | 2024-10-08 | — | — | US | disclosed |
| US-11918645-B2 | Vaccines against hepatitis B virus | ALTIMMUNE UK LIMITED (GB) | 2024-03-05 | — | — | US | disclosed |
| US-20240042007-A1 | Fluorocarbon-Linked Peptide Formulation | ALTIMMUNE UK LTD (GB) | 2024-02-08 | — | — | US | disclosed |
| US-11648305-B2 | Fluorocarbon-linked peptide formulation | Altimmune UK Ltd. (GB) | 2023-05-16 | — | — | US | disclosed |
| US-20230090379-A1 | VACCINES AGAINST HEPATITIS B VIRUS | ALTIMMUNE UK LIMITED (GB) | 2023-03-23 | — | — | US | disclosed |
| US-11382969-B2 | Vaccines against Hepatitis B virus | ALTIMMUNE UK LTD (GB) | 2022-07-12 | — | — | US | disclosed |
| CN-114686044-A | Inkjet ink composition, ink set, and recording method | 精工爱普生株式会社 | 2022-07-01 | — | — | CN | disclosed |
| US-20220204787-A1 | Ink Jet Ink Composition, Ink Set, And Recording Method | SEIKO EPSON CORPORATION (JP) | 2022-06-30 | — | — | US | disclosed |
| EP-4019597-A1 | INK JET INK COMPOSITION, INK SET, AND RECORDING METHOD | Seiko Epson Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| EP-3995146-A1 | VACCINES AGAINST HEPATITIS B VIRUS | ALTIMMUNE UK LIMITED (GB) | 2022-05-11 | — | — | EP | disclosed |
| EP-1686425-B1 | METHOD FOR FORMING MULTILAYER RESIST | DAIKIN IND LTD (JP) | 2018-06-13 | — | — | EP | disclosed |
| US-7521168-B2 | Compound that has a reduction potential higher than that of diphenyl iodonium salt and generates an acid upon irradiation of an actinic ray or radiation. | FUJIFILM CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-20070196763-A1 | Method of forming laminated resist | DAIKIN INDUSTRIES, LTD. | 2007-08-23 | — | — | US | disclosed |
| US-7214467-B2 | Photosensitive resin composition | FUJIFILM CORPORATION (JP) | 2007-05-08 | — | — | US | disclosed |
| US-7202015-B2 | Positive photoresist composition and pattern making method using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2007-04-10 | — | — | US | disclosed |
| US-7198880-B2 | Positive resist composition | FUJIFILM CORPORATION (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7163776-B2 | Positive-working resist composition | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
| US-7160666-B2 | Photosensitive resin composition | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-09 | — | — | US | disclosed |
| US-7157206-B2 | Resin containing an acid-decomposable group such as bis(trifluoromethyl)methanol group, to generate alkali-soluble group, and acid generators selected from fluorine-substituted or non-fluorine substituted aromatic or aliphatic carboxylic acid generators or sulfonic acid generators; microlithography | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| EP-1686425-A1 | METHOD FOR FORMING MULTILAYER RESIST | Daikin Industries, Ltd. (JP) | 2006-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230090379-A1 | VACCINES AGAINST HEPATITIS B VIRUS | HLA-DRB1, CD4, HLA-B | THRB 457/4885LMNA 2272/4885ALKBH5 486/4885 |
| US-11918645-B2 | Vaccines against hepatitis B virus | HLA-DRB1, CD4, HLA-B | THRB 457/4885LMNA 2272/4885ALKBH5 486/4885 |
| US-11382969-B2 | Vaccines against Hepatitis B virus | CD4, HLA-DRB1, HLA-B | THRB 425/4885LMNA 2172/4885ALKBH5 385/4885 |
| US-20240042007-A1 | Fluorocarbon-Linked Peptide Formulation | VIP, FGB, LNPEP | THRB 3856/4885LMNA 442/4885ALKBH5 3814/4885 |
| US-11648305-B2 | Fluorocarbon-linked peptide formulation | VIP, FGB, LNPEP | THRB 3856/4885LMNA 442/4885ALKBH5 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.